高级检索
当前位置: 首页 > 详情页

Cyclic glycine-proline normalizes systolic blood pressure in high-fat diet-induced obese male rats.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [a]The Seventh Affiliated Hospital, Sun Yat-sen University, 628 Zhenyuan Road, Guangming District, Shenzhen, 518107, China [b]Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun District, Guangzhou, 510000, China [c]Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangzhou Higher Education Mega Center, 280Waihuangdong Road, Guangzhou, 510008, China [d]The Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University ofAuckland, 85 Park Road, Grafton, Auckland, 1142, New Zealand [e]Centre for Brain Research, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton,Auckland, 1142, New Zealand [f]Brain Research New Zealand, A Centre of Research Excellence, New Zealand [g]The Liggins Institute, University of Auckland, 85 Park Road, Grafton, Auckland, 1142, New Zealand [h]Department of Medicinal Chemistry, School of Chemistry, Faculty of Science, University of Auckland, 1142, New Zealand
出处:
ISSN:

关键词: Insulin-like growthfactor-1 (IGF-1) Cyclic glycine-proline(cGP) Systolic blood pressure Retroperitoneal fat weight High fat diet Young male rats

摘要:
Insulin-like growth factor (IGF)-1 deficiency is associated with a range of metabolic disorders. Cyclic glycine-proline (cGP) is a natural nutrient and regulates the amount of active IGF-1 in plasma. Plasma cGP decreases in hypertensive women whereas increases in obese women, suggesting its involvement in cardio-metabolic function. We therefore examined the effects of cGP on metabolic profiles and blood pressure in high-fat diet (HFD)-induced obese male rats. Male rats were fed either a HFD or a standard chow diet (STD) ad-libitum from 3 to 15 weeks of age. Rats were administered either saline or cGP from 11 to 15 weeks of age. At 14 weeks of age, systolic-blood pressure (SBP) was measured by tail-cuff plethysmography and body composition quantified by DEXA. Blood and retroperitoneal fat tissues were collected. Plasma concentrations of insulin, IGF-1, IGF binding protein (IGFBP)-3 and cGP were evaluated using ELISA and HPLC-MS respectively. Compared to STD, HFD feeding increased SBP, total fat mass and fat/lean ratio, retroperitoneal fat weight, fasting plasma insulin and cGP concentrations whereas decreased plasma IGF-1 and IGFBP-3 concentrations. Administration of cGP reduced SBP and retroperitoneal fat weight, but had no effect on body composition and plasma insulin concentrations. HFD-associated decreases in IGFBP-3 and increases in cGP represent an autocrine response to normalize IGF-1 function through improving the amount of bioavailable IGF-1 in the circulation of obese male rats. The beneficial effects of cGP on SBP and retroperitoneal fat mass may suggest a therapeutic potential for cGP in HFD-associated cardio-metabolic complications. Copyright © 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 医学
小类 | 3 区 心脏和心血管系统 3 区 内分泌学与代谢 3 区 营养学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 心脏和心血管系统 3 区 内分泌学与代谢 3 区 营养学
JCR分区:
出版当年[2018]版:
Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Q2 ENDOCRINOLOGY & METABOLISM Q2 NUTRITION & DIETETICS
最新[2023]版:
Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Q2 ENDOCRINOLOGY & METABOLISM Q2 NUTRITION & DIETETICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [a]The Seventh Affiliated Hospital, Sun Yat-sen University, 628 Zhenyuan Road, Guangming District, Shenzhen, 518107, China [b]Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun District, Guangzhou, 510000, China [c]Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangzhou Higher Education Mega Center, 280Waihuangdong Road, Guangzhou, 510008, China [d]The Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University ofAuckland, 85 Park Road, Grafton, Auckland, 1142, New Zealand [e]Centre for Brain Research, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton,Auckland, 1142, New Zealand
通讯作者:
通讯机构: [d]The Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University ofAuckland, 85 Park Road, Grafton, Auckland, 1142, New Zealand [e]Centre for Brain Research, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton,Auckland, 1142, New Zealand [f]Brain Research New Zealand, A Centre of Research Excellence, New Zealand [*1]Department of Pharmacology and Clinical Pharmacology, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, 1124, New Zealand.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号